Work

Dupilumab Reduces Exacerbations and FeNO Levels and Improves Asthma Control with Inhaled Corticosteroid Withdrawal: a Phase 2 Study

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa5371

Authors: Michael E. Wechsler, David J. Jackson, Klaus F. Rabe, Ian D. Pavord, J. Christian Virchow, Rohit Katial, Elliot Israel, Changming Xia, Mena Soliman, Nami Pandit-Abid, Juby A. Jacob-Nara, Harry Sacks, Paul J. Rowe, Yamo Deniz

Institutions: National Jewish Health, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, Christian-Albrechts-Universität zu Kiel, German Center for Lung Research, LungenClinic Grosshansdorf, National Institute for Health and Care Research, University of Oxford, University of Rostock, Brigham and Women's Hospital, Harvard University, Regeneron (United States), Sanofi (United States)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404127284

Cites:

Cited by:

Related to: 10